Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Mechanism of Children With Relapsed and Refractory Rhabdomyosarcoma (RMS)

NCT06040229 is registered in ClinicalTrials.gov with Shandong First Medical University as lead sponsor.

NCT NCT06040229
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06040229 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Mechanism of Children With Relapsed and Refractory Rhabdomyosarcoma (RMS)
Lead sponsor
Shandong First Medical University
Phase
Observational
Overall status
Completed
Start date
April 1, 2023
Completion date
September 1, 2023
Enrollment
6 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alveolar childhood rhabdomyosarcoma, embryonal childhood rhabdomyosarcoma, recurrent childhood rhabdomyosarcoma